Inventaire - your friends and communities are your best library

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

Published in: Antiviral Research

Date of publication: November 1, 2000

Main subject: oseltamivir

Bibliographic databases:

Cites articles 29

Date

Title

Authors

June 1, 1965

THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.
October 1976

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

,
May 1, 1981

Study of rimantadine in the USSR: a review of the literature,Study of Rimantadine in the USSR: A Review of the Literature
May 1, 1988

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
January 1, 1989

The neuraminidase of influenza virus
February 1, 1990

Prophylaxis and treatment of influenza
July 1990

Anti-influenza virus activity of the compound LY253963
June 3, 1993

Rational design of potent sialidase-based inhibitors of influenza virus replication
March 1, 1993

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
July 1993

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
August 1, 1994

Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid
October 1, 1995

Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
January 1, 1996

Neuraminidase inhibitors as potential anti-influenza drugs
March 1, 1996

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en
November 1, 1996

Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme
October 1, 1997

A pandemic warning?

,
February 1, 1998

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

, ,
December 1, 1998

Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
February 1, 1998

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor
January 1, 1998

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

, ,
December 1, 1998

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071
April 1, 1999

Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong
August 1, 1999

Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

, ,
July 1, 1999

First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.
July 1, 1999

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
February 1, 1999

Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic
September 1, 1999

Human infection with influenza H9N2.

,
February 1, 2000

Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses
March 1, 2000

Influenza virus neuraminidase inhibitors

Article -

Welcome to inventaire

The library of your friends and communities

Learn more